Page last updated: 2024-11-02

pentobarbital and Cardiotoxicity

pentobarbital has been researched along with Cardiotoxicity in 1 studies

Pentobarbital: A short-acting barbiturate that is effective as a sedative and hypnotic (but not as an anti-anxiety) agent and is usually given orally. It is prescribed more frequently for sleep induction than for sedation but, like similar agents, may lose its effectiveness by the second week of continued administration. (From AMA Drug Evaluations Annual, 1994, p236)
pentobarbital : A member of the class of barbiturates, the structure of which is that of barbituric acid substituted at C-5 by ethyl and sec-pentyl groups.

Cardiotoxicity: Damage to the HEART or its function secondary to exposure to toxic substances such as drugs used in CHEMOTHERAPY; IMMUNOTHERAPY; or RADIATION.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19901 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
CALESNICK, B1
SMITH, NH1
BEUTNER, R1

Other Studies

1 other study available for pentobarbital and Cardiotoxicity

ArticleYear
Combined action of cardiotoxic drugs; a study on the acute toxicity of combined quinidine, meperidine, pentobarbital, procaine and procaine amide.
    The Journal of pharmacology and experimental therapeutics, 1951, Volume: 102, Issue:2

    Topics: Cardiotoxicity; Heart; Hedera; Meperidine; Pentobarbital; Procainamide; Procaine; Quinidine

1951